Table 4.
Methodological quality of case series by means of the JBI.
| Author | Outcome reported | |
|---|---|---|
| Primary | Secondary | |
| (a) Alveolar ridge augmentation | ||
| El Chaar et al[27] | • Marginal bone loss: 7 mo: mesial: 0.26 ± 0.52 mm, distal: 0 mm, average: 0.13 ± 0.38 mm 16.13 mo: mesial: 0.31 ± 0.55 mm, distal: 0.14 ± 0.21 mm, average: 0.22 ± 0.39 mm |
• Implant failure: 0 • Postoperative complications: 0 |
| Chen et al[28] | • Ridge width gain (4 mo): 4.73 ± 0.7 mm (P < .05) • Ridge height gain (4 mo): 5.55 ± 0.87 mm (P < .05) • Horizontal graft resorption: 4 mo: 1.66 ± 2.85 mm; 1 y: 2.44 ± 2.85 mm; 2 y: 2.69 ± 2.77 mm; 3 y: 2.72 ± 3.18 mm (P < .05) |
• Implant failure: 0 • Postoperative complications: 1 BR exposed |
| Ding et al[8] | Ridge width gain (12 mo): 0 mm plane: 1.95 ± 0.19 mm; 1 mm plane: 2.39 ± 0.38 mm; 2 mm plane: 2.91 ± 0.56 mm; 3 mm plane: 3.28 ± 0.63 mm Marginal bone loss (12 mo): buccal: 1.46 ± 0.38 mm Horizontal graft resorption (12 mo): 0 mm plane: 0.45 ± 0.28 mm (17.78 ± 9.03%); 1 mm plane: 0.41 ± 0.36 mm (13.86 ± 10.55%); 2 mm plane: 0.43 ± 0.31 mm (13.02 ± 8.85%); 3 mm plane: 0.48 ± 0.31 mm (12.96 ± 8.36%) |
Implant failure: 0 Postoperative complications: 1 fracture of the wound |
| Fukuda et al[6] | • Implant failure: 0 • Postoperative complications: 1 exposed chin bone necrosed |
|
| Flanagan[29] | • Implant failure: 0 • Postoperative complications: 0 |
|
| Nord et al[30] | • Vertical graft resorption: 6 wk: 5.6% ± 9.7%; 6 mo: 8.0% ± 11.8%; 12 mo: 8.6% ± 8.3% |
• Implant failure: 5 • Postoperative complications: 3 periimplant bone loss 2–3 mm |
| Wychowanski et al[31] | • Ridge height gain: Test: 4.3 ± 1.3 mm Control: 4.4 ± 1.5 mm |
• Implant stability (PTV): Primary: Test: −3.2 ± 1.3 Control: −1.2 ± 1.6 24 mo: Test: −3.7 ± 1.1 Control: −3.6 ± 1.2 • Implant failure: Test: 4 Control: 1 • Postoperative complications: Test: 3 poor healing Control: 0 |
| Yawale et al[32] | • Marginal bone loss: 3 mo: mesial: 0.70 ± 0.06 mm, distal: 1.22 ± 0.16 mm 6 mo: mesial: 0.69 ± 0.07 mm, distal: 1.14 ± 0.13 mm |
• Implant failure: 1 • Postoperative complications: 0 |
| (b) Extraction socket augmentation | ||
| Chandra et al[33] | • Ridge height gain (6 mo): Buccal plate: Test: 3.09 ± 1.6 mm Control: 1.90 ± 0.94 mm (P < .01) Palatal/lingual plate: Test: 3.31 ± 2.66 mm Control: 1.99 ± 1.22 mm (P < .01) |
• Bone density (HU, 6 mo): Test: 659.6 ± 133.8 Control: 552.1 ± 65.6 (P = .042) • Implant stability (ISQ, 6 mo): Test: 61.60 ± 8.9 Control: 45.02 ± 6.33 (P = .034) • Implant failure: Test: 2 Control: 0 • Postoperative complications: Test: 3 soft tissue dehiscence, 3 pain and swelling Control: 1 soft tissue dehiscence, 3 pain and swelling |
| Giraddi and Saifi[21] | • Ridge width gain (9 mo): Mesial: 3.70 ± 1.10 mm, distal: 3.69 ± 1.10 mm • Marginal bone loss: 6 mo: mesial: 0.67 ± 0.34 mm, distal: 0.64 ± 0.21 mm 9 mo: mesial: 0.76 ± 0.38 mm, distal: 0.78 ± 0.23 mm |
• Implant failure: 1 • Postoperative complications: 1 soft tissue dehiscence |
| Omara et al[34] | • Marginal bone loss: 6 mo: 0.26 ± 0.87 mm (P = .321) • Vertical graft resorption: 6 mo: 0.26 ± 0.87 mm (1.89% ± 6.41%) (P = .328) |
• Bone density (HU, 6 mo): Ring-implant interface: mesial: 393.21 ± 421.52 (P = .008), distal: 282.60 ± 457.48 (P = .056), buccal: 429.69 ± 571.12 (P = .024), lingual: 263.86 ± 505.57 (P = .098); Ring-alveolus interface: mesial: 420.43 ± 360.66 (P = .002), distal: 325.28 ± 272.45 (P = .002) • Implant failure: 0 • Postoperative complications: 2 transient numbness of the lower lip, 1 cracked BR |
| Yuce et al[35] | • Implant failure: 0 • Postoperative complications: 1 BR infection |
|
| (c) Sinus floor elevation | ||
| Rizzo et al[22] | • Implant failure: 0 • Postoperative complications: 0 |
|
| Sindel et al[23] | • Marginal bone loss (5 implants): 2.4 ± 0.49 mm | • Implant failure: 1 • Postoperative complications: 1 soft tissue dehiscence |
BR = bone ring, Hu = Hounsfield Unit, ISQ = implant stability quotient, PTV = Periotest value.